Agenda

Browse through all events.
Day 1
07 May 2020

Evidence in the time of COVID-19

The COVID-19 pandemic has created many immediate and urgent needs for more and better data and evidence about how to protect public health. However, most evidence-generating activities in development have long timelines. How can we shorten timelines for evaluation and synthesis to respond for immediate needs for evidence?

Read blog | Watch video
Day 2
12 May 2020

3ie evidence portal – amplifying the effects of available research

What if we had all the research at our fingertips? How would that change things? Learn more about the new Development Evidence Portal, a comprehensive repository of rigorous evidence on what works in international development, consisting of rigorous studies and synthesis of studies conducted in low- and middle-income countries.

Read blog | Watch video
Day 3
14 May 2020

So the intervention is effective… but what will it cost?

This virtual session will be an interview-style panel discussion focusing broadly on the use of cost evidence in impact evaluation. Each panellist brings a different perspective to the topic, ranging from real-world examples of the critical importance of cost evidence for policymaking to key practical and methodological considerations for research to the global “market” in international development for cost analysis in impact evaluation.

Read blog | Watch video
Day 4
21 May 2020

Methodological and practical barriers to integrating Cost-effectiveness Analysis and Cost-Benefit Analysis into impact evaluations

This session will have key discussions based on comparisons between practices in the Health Sector and International Development. What mechanisms should the field of international development put in place to advance both the methods and practice of conducting CEA?

Read blog | Watch video
Day 5
28 May 2020

Scaling up

This panel discussion will focus on scalability. If our purpose is the improvement of effective interventions that can improve lives, we need to know not just if interventions are effective under ideal conditions, but if they can be scaled and the cost implications of doing so.

Read blog | Watch video